0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
COVID-19 Impact on Bioinformatics in IVD Testing Market, Global Research Reports 2020-2021
Published Date: June 2020
|
Report Code: QYRE-Othe-1H310
Home | Category |Health |Medical Facilities & Services
Bioinformatics in IVD Testing Market

COVID-19 Impact on Bioinformatics in IVD Testing Market, Global Research Reports 2020-2021

Code: QYRE-Othe-1H310
Report
June 2020
98 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Bioinformatics is a multidisciplinary research field that combines computer science, biology, statistics and mathematics for the management of biological information.

North America holds the largest market share in this market presently due to the increase in health awareness and rise in patient expenditure. Asia-Pacific is expected to capture the market in the forecast period due to the rising prevalence of cancer and other rare diseases.

This report provides a complete quantitative data and qualitative analysis on the global market for Bioinformatics in IVD Testing. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.

Prior to COVID-19, the global market for Bioinformatics in IVD Testing was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Bioinformatics in IVD Testing is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.

This report covers market size and forecasts of Bioinformatics in IVD Testing, including the following market information:

Global Bioinformatics in IVD Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)

Global Bioinformatics in IVD Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)

Global Bioinformatics in IVD Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)

Global Bioinformatics in IVD Testing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

 

Key market players

Major competitors identified in this market include Affymetrix, AssureRx Health Inc., Aperico Technologies Inc., Biodesix Inc., Bioreference Laboratories Inc., CardioDx Inc., Datech Oncology, Life Technologies, Pathogenica, Medtronic Inc., Signal genetics, One Lambda Inc., etc.

 

Based on the Region:

  • Asia-Pacific (China, Japan, South Korea, India and ASEAN)
  • North America (US and Canada) 
  • Europe (Germany, France, UK and Italy)
  • Rest of World (Latin America, Middle East & Africa)

 

Based on the Type:

  • Hardware
  • Software

 

Based on the Application:

  • Cardiovascular Diseases
  • Chronic Diseases
  • Diabetes
  • Cancer
  • Others

 

    1.1 Research Scope

    1.2 Market Segmentation

    1.3 Research Objectives

    1.4 Research Methodology

        1.4.1 Research Process

        1.4.2 Data Triangulation

        1.4.3 Research Approach

        1.4.4 Base Year

    1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

        1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

        1.5.2 Covid-19 Impact: Commodity Prices Indices

        1.5.3 Covid-19 Impact: Global Major Government Policy

    1.6 The Covid-19 Impact on Bioinformatics in IVD Testing Industry

    1.7 COVID-19 Impact: Bioinformatics in IVD Testing Market Trends

 

2 Global Bioinformatics in IVD Testing Quarterly Market Size Analysis

    2.1 Bioinformatics in IVD Testing Business Impact Assessment - COVID-19

        2.1.1 Global Bioinformatics in IVD Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

    2.2 Global Bioinformatics in IVD Testing Quarterly Market Size 2020-2021

    2.3 COVID-19-Driven Market Dynamics and Factor Analysis

        2.3.1 Drivers

        2.3.2 Restraints

        2.3.3 Opportunities

        2.3.4 Challenges

 

3 Quarterly Competitive Assessment, 2020

    3.1 By Players, Global Bioinformatics in IVD Testing Quarterly Market Size, 2019 VS 2020

    3.2 By Players, Bioinformatics in IVD Testing Headquarters and Area Served

    3.3 Date of Key Players Enter into Bioinformatics in IVD Testing Market

    3.4 Key Players Bioinformatics in IVD Testing Product Offered

    3.5 Mergers & Acquisitions, Expansion Plans

 

4 Impact of Covid-19 on Bioinformatics in IVD Testing Segments, By Type

    4.1 Introduction

        1.4.1 Hardware

        1.4.2 Software

    4.2 By Type, Global Bioinformatics in IVD Testing Market Size, 2019-2021

 

5 Impact of Covid-19 on Bioinformatics in IVD Testing Segments, By Application

    5.1 Overview

        5.5.1 Cardiovascular Diseases

        5.5.2 Chronic Diseases

        5.5.3 Diabetes

        5.5.4 Cancer

        5.5.5 Others

    5.2 By Application, Global Bioinformatics in IVD Testing Market Size, 2019-2021

        5.2.1 By Application, Global Bioinformatics in IVD Testing Market Size by Application, 2019-2021

 

6 Geographic Analysis

    6.1 Introduction

    6.2 North America

        6.2.1 Macroeconomic Indicators of US

        6.2.2 US

        6.2.3 Canada

    6.3 Europe

        6.3.1 Macroeconomic Indicators of Europe

        6.3.2 Germany

        6.3.3 France

        6.3.4 UK

        6.3.5 Italy

    6.4 Asia-Pacific

        6.4.1 Macroeconomic Indicators of Asia-Pacific

        6.4.2 China

        6.4.3 Japan

        6.4.4 South Korea

        6.4.5 India

        6.4.6 ASEAN

    6.5 Rest of World

        6.5.1 Latin America

        6.5.2 Middle East and Africa

 

7 Company Profiles

    7.1 Affymetrix

        7.1.1 Affymetrix Business Overview

        7.1.2 Affymetrix Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.1.3 Affymetrix Bioinformatics in IVD Testing Product Introduction

        7.1.4 Affymetrix Response to COVID-19 and Related Developments

    7.2 AssureRx Health Inc.

        7.2.1 AssureRx Health Inc. Business Overview

        7.2.2 AssureRx Health Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.2.3 AssureRx Health Inc. Bioinformatics in IVD Testing Product Introduction

        7.2.4 AssureRx Health Inc. Response to COVID-19 and Related Developments

    7.3 Aperico Technologies Inc.

        7.3.1 Aperico Technologies Inc. Business Overview

        7.3.2 Aperico Technologies Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.3.3 Aperico Technologies Inc. Bioinformatics in IVD Testing Product Introduction

        7.3.4 Aperico Technologies Inc. Response to COVID-19 and Related Developments

    7.4 Biodesix Inc.

        7.4.1 Biodesix Inc. Business Overview

        7.4.2 Biodesix Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.4.3 Biodesix Inc. Bioinformatics in IVD Testing Product Introduction

        7.4.4 Biodesix Inc. Response to COVID-19 and Related Developments

    7.5 Bioreference Laboratories Inc.

        7.5.1 Bioreference Laboratories Inc. Business Overview

        7.5.2 Bioreference Laboratories Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.5.3 Bioreference Laboratories Inc. Bioinformatics in IVD Testing Product Introduction

        7.5.4 Bioreference Laboratories Inc. Response to COVID-19 and Related Developments

    7.6 CardioDx Inc.

        7.6.1 CardioDx Inc. Business Overview

        7.6.2 CardioDx Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.6.3 CardioDx Inc. Bioinformatics in IVD Testing Product Introduction

        7.6.4 CardioDx Inc. Response to COVID-19 and Related Developments

    7.7 Datech Oncology

        7.7.1 Datech Oncology Business Overview

        7.7.2 Datech Oncology Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.7.3 Datech Oncology Bioinformatics in IVD Testing Product Introduction

        7.7.4 Datech Oncology Response to COVID-19 and Related Developments

    7.8 Life Technologies, Pathogenica

        7.8.1 Life Technologies, Pathogenica Business Overview

        7.8.2 Life Technologies, Pathogenica Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.8.3 Life Technologies, Pathogenica Bioinformatics in IVD Testing Product Introduction

        7.8.4 Life Technologies, Pathogenica Response to COVID-19 and Related Developments

    7.9 Medtronic Inc.

        7.9.1 Medtronic Inc. Business Overview

        7.9.2 Medtronic Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.9.3 Medtronic Inc. Bioinformatics in IVD Testing Product Introduction

        7.9.4 Medtronic Inc. Response to COVID-19 and Related Developments

    7.10 Signal genetics

        7.10.1 Signal genetics Business Overview

        7.10.2 Signal genetics Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.10.3 Signal genetics Bioinformatics in IVD Testing Product Introduction

        7.10.4 Signal genetics Response to COVID-19 and Related Developments

    7.11 One Lambda Inc.

        7.11.1 One Lambda Inc. Business Overview

        7.11.2 One Lambda Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.11.3 One Lambda Inc. Bioinformatics in IVD Testing Product Introduction

        7.11.4 One Lambda Inc. Response to COVID-19 and Related Developments

 

8 Key Findings

 

9 Appendix

    9.1 About US

    9.2 Disclaimer

 
 

Bioinformatics is a multidisciplinary research field that combines computer science, biology, statistics and mathematics for the management of biological information.

North America holds the largest market share in this market presently due to the increase in health awareness and rise in patient expenditure. Asia-Pacific is expected to capture the market in the forecast period due to the rising prevalence of cancer and other rare diseases.

This report provides a complete quantitative data and qualitative analysis on the global market for Bioinformatics in IVD Testing. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.

Prior to COVID-19, the global market for Bioinformatics in IVD Testing was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Bioinformatics in IVD Testing is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.

This report covers market size and forecasts of Bioinformatics in IVD Testing, including the following market information:

Global Bioinformatics in IVD Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)

Global Bioinformatics in IVD Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)

Global Bioinformatics in IVD Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)

Global Bioinformatics in IVD Testing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

 

Key market players

Major competitors identified in this market include Affymetrix, AssureRx Health Inc., Aperico Technologies Inc., Biodesix Inc., Bioreference Laboratories Inc., CardioDx Inc., Datech Oncology, Life Technologies, Pathogenica, Medtronic Inc., Signal genetics, One Lambda Inc., etc.

 

Based on the Region:

  • Asia-Pacific (China, Japan, South Korea, India and ASEAN)
  • North America (US and Canada) 
  • Europe (Germany, France, UK and Italy)
  • Rest of World (Latin America, Middle East & Africa)

 

Based on the Type:

  • Hardware
  • Software

 

Based on the Application:

  • Cardiovascular Diseases
  • Chronic Diseases
  • Diabetes
  • Cancer
  • Others

 

Read More

    1.1 Research Scope

    1.2 Market Segmentation

    1.3 Research Objectives

    1.4 Research Methodology

        1.4.1 Research Process

        1.4.2 Data Triangulation

        1.4.3 Research Approach

        1.4.4 Base Year

    1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

        1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

        1.5.2 Covid-19 Impact: Commodity Prices Indices

        1.5.3 Covid-19 Impact: Global Major Government Policy

    1.6 The Covid-19 Impact on Bioinformatics in IVD Testing Industry

    1.7 COVID-19 Impact: Bioinformatics in IVD Testing Market Trends

 

2 Global Bioinformatics in IVD Testing Quarterly Market Size Analysis

    2.1 Bioinformatics in IVD Testing Business Impact Assessment - COVID-19

        2.1.1 Global Bioinformatics in IVD Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

    2.2 Global Bioinformatics in IVD Testing Quarterly Market Size 2020-2021

    2.3 COVID-19-Driven Market Dynamics and Factor Analysis

        2.3.1 Drivers

        2.3.2 Restraints

        2.3.3 Opportunities

        2.3.4 Challenges

 

3 Quarterly Competitive Assessment, 2020

    3.1 By Players, Global Bioinformatics in IVD Testing Quarterly Market Size, 2019 VS 2020

    3.2 By Players, Bioinformatics in IVD Testing Headquarters and Area Served

    3.3 Date of Key Players Enter into Bioinformatics in IVD Testing Market

    3.4 Key Players Bioinformatics in IVD Testing Product Offered

    3.5 Mergers & Acquisitions, Expansion Plans

 

4 Impact of Covid-19 on Bioinformatics in IVD Testing Segments, By Type

    4.1 Introduction

        1.4.1 Hardware

        1.4.2 Software

    4.2 By Type, Global Bioinformatics in IVD Testing Market Size, 2019-2021

 

5 Impact of Covid-19 on Bioinformatics in IVD Testing Segments, By Application

    5.1 Overview

        5.5.1 Cardiovascular Diseases

        5.5.2 Chronic Diseases

        5.5.3 Diabetes

        5.5.4 Cancer

        5.5.5 Others

    5.2 By Application, Global Bioinformatics in IVD Testing Market Size, 2019-2021

        5.2.1 By Application, Global Bioinformatics in IVD Testing Market Size by Application, 2019-2021

 

6 Geographic Analysis

    6.1 Introduction

    6.2 North America

        6.2.1 Macroeconomic Indicators of US

        6.2.2 US

        6.2.3 Canada

    6.3 Europe

        6.3.1 Macroeconomic Indicators of Europe

        6.3.2 Germany

        6.3.3 France

        6.3.4 UK

        6.3.5 Italy

    6.4 Asia-Pacific

        6.4.1 Macroeconomic Indicators of Asia-Pacific

        6.4.2 China

        6.4.3 Japan

        6.4.4 South Korea

        6.4.5 India

        6.4.6 ASEAN

    6.5 Rest of World

        6.5.1 Latin America

        6.5.2 Middle East and Africa

 

7 Company Profiles

    7.1 Affymetrix

        7.1.1 Affymetrix Business Overview

        7.1.2 Affymetrix Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.1.3 Affymetrix Bioinformatics in IVD Testing Product Introduction

        7.1.4 Affymetrix Response to COVID-19 and Related Developments

    7.2 AssureRx Health Inc.

        7.2.1 AssureRx Health Inc. Business Overview

        7.2.2 AssureRx Health Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.2.3 AssureRx Health Inc. Bioinformatics in IVD Testing Product Introduction

        7.2.4 AssureRx Health Inc. Response to COVID-19 and Related Developments

    7.3 Aperico Technologies Inc.

        7.3.1 Aperico Technologies Inc. Business Overview

        7.3.2 Aperico Technologies Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.3.3 Aperico Technologies Inc. Bioinformatics in IVD Testing Product Introduction

        7.3.4 Aperico Technologies Inc. Response to COVID-19 and Related Developments

    7.4 Biodesix Inc.

        7.4.1 Biodesix Inc. Business Overview

        7.4.2 Biodesix Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.4.3 Biodesix Inc. Bioinformatics in IVD Testing Product Introduction

        7.4.4 Biodesix Inc. Response to COVID-19 and Related Developments

    7.5 Bioreference Laboratories Inc.

        7.5.1 Bioreference Laboratories Inc. Business Overview

        7.5.2 Bioreference Laboratories Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.5.3 Bioreference Laboratories Inc. Bioinformatics in IVD Testing Product Introduction

        7.5.4 Bioreference Laboratories Inc. Response to COVID-19 and Related Developments

    7.6 CardioDx Inc.

        7.6.1 CardioDx Inc. Business Overview

        7.6.2 CardioDx Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.6.3 CardioDx Inc. Bioinformatics in IVD Testing Product Introduction

        7.6.4 CardioDx Inc. Response to COVID-19 and Related Developments

    7.7 Datech Oncology

        7.7.1 Datech Oncology Business Overview

        7.7.2 Datech Oncology Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.7.3 Datech Oncology Bioinformatics in IVD Testing Product Introduction

        7.7.4 Datech Oncology Response to COVID-19 and Related Developments

    7.8 Life Technologies, Pathogenica

        7.8.1 Life Technologies, Pathogenica Business Overview

        7.8.2 Life Technologies, Pathogenica Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.8.3 Life Technologies, Pathogenica Bioinformatics in IVD Testing Product Introduction

        7.8.4 Life Technologies, Pathogenica Response to COVID-19 and Related Developments

    7.9 Medtronic Inc.

        7.9.1 Medtronic Inc. Business Overview

        7.9.2 Medtronic Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.9.3 Medtronic Inc. Bioinformatics in IVD Testing Product Introduction

        7.9.4 Medtronic Inc. Response to COVID-19 and Related Developments

    7.10 Signal genetics

        7.10.1 Signal genetics Business Overview

        7.10.2 Signal genetics Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.10.3 Signal genetics Bioinformatics in IVD Testing Product Introduction

        7.10.4 Signal genetics Response to COVID-19 and Related Developments

    7.11 One Lambda Inc.

        7.11.1 One Lambda Inc. Business Overview

        7.11.2 One Lambda Inc. Bioinformatics in IVD Testing Quarterly Revenue, 2020

        7.11.3 One Lambda Inc. Bioinformatics in IVD Testing Product Introduction

        7.11.4 One Lambda Inc. Response to COVID-19 and Related Developments

 

8 Key Findings

 

9 Appendix

    9.1 About US

    9.2 Disclaimer

Read More
 
 
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Enterprise License

Electronic (PDF)
$6500
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global Neuropathy Screening Devices Market Insights and Forecast to 2026
Global Neuropathy Screening Devices Market Insights and Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-8A3317
Fri Jul 31 00:00:00 UTC 2020

Add to Cart

Global Hepatitis Diagnostics Test Market Size Status and Forecast 2020 2026
Global Hepatitis Diagnostics Test Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-20T3047
Fri Jul 31 00:00:00 UTC 2020

Add to Cart

Global Point of Care Diagnostics POCD Market Size Status and Forecast 2020 2026
Global Point of Care Diagnostics (POCD) Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-31E2963
Fri Jul 31 00:00:00 UTC 2020

Add to Cart

Global Transplant Diagnostics Market Size Status and Forecast 2020 2026
Global Transplant Diagnostics Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-17V3224
Fri Jul 31 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0